EYPT
Eyepoint Pharmaceuticals Inc
3.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +121.9% | -7.3% | -1.5% | -7.2% | +39.1% | -13.4% | -16.9% | -16.4% | +44.6% | -20.8% | -20.8% | |
| – | +129.6% | -7.9% | -7.2% | -8.9% | +42.7% | -14.7% | -18.9% | -18.5% | +52.1% | -24.1% | -24.3% | |
| – | +111.4% | -3.6% | -66.5% | -12.1% | +24.9% | -14.6% | -16.5% | +4.8% | +36.5% | -23.7% | +42.1% | |
| – | +143.4% | -9.6% | -6.4% | -9.4% | +46.1% | -14.2% | -19.6% | -20.2% | +50.0% | -27.3% | -18.9% | |
| – | +66.7% | +274.5% | -54.4% | -72.5% | +60.6% | -27.2% | +41.4% | +67.2% | -37.7% | +77.7% | -92.6% | |
| – | -14.7% | +9.0% | -13.7% | -23.6% | -17.9% | -7.6% | +25.8% | -21.2% | -14.1% | -31.1% | +50.6% | |
| – | -12.4% | -10.7% | +21.0% | -14.3% | -0.3% | -21.7% | -14.1% | -6.6% | +12.4% | -0.2% | +7.0% | |
| – | -1.0% | -1.1% | -0.8% | -21.4% | +0.5% | -15.0% | -20.4% | -9.3% | +23.0% | +1.2% | +12.0% | |
| – | -46.8% | +95.0% | +2.9% | +14.1% | -3.3% | +41.8% | – | – | +3.1% | +3.1% | +22.5% | |
| – | -32.1% | +8.9% | +101.9% | -48.6% | +59.6% | +40.1% | +19.9% | -48.8% | +4.1% | +79.3% | -8.2% | |
| – | +354.3% | -6.2% | -8.7% | -4.2% | +53.8% | -11.3% | -17.6% | -18.6% | +52.9% | -24.7% | -27.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.0% | +25.5% | +0.6% | +2.3% | +18.6% | +8.1% | +0.2% | +0.3% | +18.3% | +3.6% | +0.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.